LATTANZIO, ROSSANO
 Distribuzione geografica
Continente #
NA - Nord America 3.781
EU - Europa 2.747
AS - Asia 2.475
SA - Sud America 404
AF - Africa 61
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.482
Nazione #
US - Stati Uniti d'America 3.680
SG - Singapore 1.079
IT - Italia 779
CN - Cina 672
IE - Irlanda 435
BR - Brasile 347
SE - Svezia 305
UA - Ucraina 246
GB - Regno Unito 221
TR - Turchia 218
DE - Germania 217
VN - Vietnam 192
FR - Francia 176
IN - India 114
FI - Finlandia 92
CA - Canada 63
RU - Federazione Russa 59
AT - Austria 45
HK - Hong Kong 41
JP - Giappone 36
PL - Polonia 33
ZA - Sudafrica 31
NL - Olanda 29
CZ - Repubblica Ceca 27
MX - Messico 22
BD - Bangladesh 21
ES - Italia 21
BE - Belgio 20
AR - Argentina 18
IQ - Iraq 15
EC - Ecuador 13
KR - Corea 13
LT - Lituania 11
AU - Australia 10
ID - Indonesia 7
PH - Filippine 7
PK - Pakistan 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
IR - Iran 6
MA - Marocco 6
UY - Uruguay 6
CO - Colombia 5
EG - Egitto 5
HN - Honduras 5
PY - Paraguay 5
RS - Serbia 5
TH - Thailandia 5
BG - Bulgaria 4
DZ - Algeria 4
KE - Kenya 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
VE - Venezuela 4
CH - Svizzera 3
EE - Estonia 3
GR - Grecia 3
KZ - Kazakistan 3
NG - Nigeria 3
RO - Romania 3
TN - Tunisia 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
CU - Cuba 2
EU - Europa 2
GD - Grenada 2
IL - Israele 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
SR - Suriname 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 9.482
Città #
Singapore 785
Chandler 498
Dublin 426
Jacksonville 328
Ashburn 319
Beijing 208
Princeton 160
Dallas 151
Los Angeles 141
Santa Clara 140
Southend 124
Pescara 113
Dearborn 112
The Dalles 107
New York 106
Izmir 102
Chieti 101
Nanjing 96
Ann Arbor 78
Altamura 73
Wilmington 73
Ho Chi Minh City 65
Munich 55
Boardman 54
Cambridge 50
Tongling 42
Hong Kong 39
Redondo Beach 39
São Paulo 38
Collecorvino 36
Dong Ket 34
Vienna 33
Denver 32
Hanoi 32
Nanchang 31
Rome 30
Milan 28
Shenyang 27
Houston 26
Tokyo 26
Washington 26
Johannesburg 25
London 25
Brooklyn 24
Buffalo 24
Woodbridge 24
Warsaw 22
Hebei 21
Hefei 21
Montreal 21
Turku 21
Ancona 20
Orem 19
Brussels 18
Chicago 18
Frankfurt am Main 18
Stockholm 18
Brno 17
Catania 17
Nuremberg 17
Atlanta 16
Jiaxing 16
Seattle 16
Tianjin 16
Helsinki 15
San Vito Chietino 15
Amsterdam 14
Boston 14
Lappeenranta 14
Ankara 13
Chennai 12
Grevenbroich 12
Jinan 12
Messina 12
Rio de Janeiro 12
Poplar 11
Seoul 11
Kunming 10
Toronto 10
Phoenix 9
Bologna 8
Da Nang 8
Guayaquil 8
Haiphong 8
Medford 8
Norwalk 8
Castignano 7
Changsha 7
Kraków 7
Mumbai 7
Oklahoma City 7
Olomouc 7
Ottawa 7
Pullman 7
San Francisco 7
Ascoli Piceno 6
Biên Hòa 6
Calgary 6
Campinas 6
Carrara 6
Totale 5.775
Nome #
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 227
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 224
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 189
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 185
A unique four-hub protein cluster associates to glioblastoma progression 182
Trop-2 is a determinant of breast cancer survival. 160
OXIDATIVE STRESS CAN DIFFERENTIALLY MODULATE WNT/β- CATENIN AND JNK SIGNALLING RELATIONSHIPS IN PRIMARY VERSUS METASTATIC CRC CELLS 159
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice 158
Trop-2 activates a dormant Na/K-ATPase/PKCa/CD9/ezrin signaling axis to override the basal growth program of cancer cells 145
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 141
Molecular expression profiling shows pseudohypoxia phenotype, vasculogenesis and mitochondrial dysfunction in head and neck paragangliomas 140
Upregulation of Trop-2 quantitatively stimulates human cancer growth 139
The Trop-2 signalling network in cancer growth 135
ABCC3 is a novel target for the treatment of pancreatic cancer 135
Prognostic relevance of LGALS3BP in human colorectal carcinoma 135
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. 133
Exosomes as pleiotropic players in pancreatic cancer 133
Molecular studies of pulmonary carcinoids 128
Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants 128
Anomalous Fusion of Right Pulmonary Artery to Aortic Arch: Case Report of a Rare and Fatal Congenital Malformation in a Newborn and a Literature Review 126
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations 124
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 123
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 123
Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations 122
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 122
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 122
Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors 122
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 122
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 120
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 119
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 119
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion 117
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 116
Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice 114
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction 113
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids 113
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 113
[Tissue microarrays] 113
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. 111
Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome 110
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 109
Molecular expression profiling shows overlapping pseudohypoxia phenotype and mitochondrial dysfunction in head and neck paragangliomas 109
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading 108
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 108
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 107
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer 107
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival 106
Pioneers in Pathology 105
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 105
NSC, SC and pleural screening of lung carcinoids for somatic mutations of MEN1 gene. 103
The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle-invasive bladder cancer 100
Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions 100
mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin 99
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 99
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 97
Cyclin A2 maintains colon homeostasis and is a prognostic factor in CRC 97
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 94
Role of phospholipase C in cell invasion and metastasis 94
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 94
Differential Regulation of Wingless-Wnt/c-Jun N-Terminal Kinase Crosstalk via Oxidative Eustress in Primary and Metastatic Colorectal Cancer Cells 93
Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. 92
Phospholipase Cgamma1 is required for metastasis development and progression 92
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 91
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 90
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 90
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 90
The role of phospholipase Cγ1 in breast cancer and its clinical significance 89
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process. 88
Proteomic meta-analysis unveils new frontiers for biomarkers research in pancreatic carcinoma 82
Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy 82
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 81
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. 81
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 78
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 75
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis 75
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer 74
Natural compounds, antioxidant, and antiandrogens in the prevention of prostate cancer: in vivo evidences from murine models and human clinical studies. 73
Loss of primary cilia promotes inflammation and carcinogenesis 71
Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice 71
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 68
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 67
The HSP90/R2TP assembly chaperone promotes cell proliferation in the intestinal epithelium 66
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 63
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer 61
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer 60
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 60
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 57
null 56
Soft tissue integration of different abutment surfaces: An experimental study with histological analysis 53
Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities 51
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 51
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 51
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance 48
null 40
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes 39
null 20
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 16
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 13
Novel Ultrastructural Insights into the Clear-Cell Carcinoma of the Pancreas: A Case Report 12
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks 5
Totale 10.016
Categoria #
all - tutte 41.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.428


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 0 0 0 0 0 83 18 10 43 48 11 55
2021/2022512 17 7 25 126 14 47 10 24 31 22 64 125
2022/20231.337 104 236 78 135 138 219 69 121 138 17 42 40
2023/2024908 52 28 67 38 52 288 175 42 25 31 12 98
2024/20252.347 89 439 375 88 76 114 161 146 241 144 227 247
2025/20262.243 357 171 363 629 517 206 0 0 0 0 0 0
Totale 10.016